Awm Investment Company, Inc. Trevena Inc Transaction History

Awm Investment Company, Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2019 Feb 13, 2020	SELL	$0.62 - $1.06 $1.41 Million - $2.42 Million	-2,278,345 Closed	0 $0
Q3 2019 Nov 12, 2019	SELL	$0.81 - $1.06 $790,911 - $1.04 Million	-976,434 Reduced 30.0%	2,278,345 $2.2 Million
Q2 2019 Aug 08, 2019	SELL	$0.94 - $1.6 $324,507 - $552,353	-345,221 Reduced 9.59%	3,254,779 $3.35 Million
Q1 2019 May 14, 2019	BUY	$0.51 - $1.88 $1.84 Million - $6.77 Million	3,600,000 New	3,600,000 $5.62 Million

Ticker TRVN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 173,680,992
Market Cap $313M
Description
Trevena, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel medicines for patients affected by central nervous system disorders. Its lead product candidates include OLINVYK (Oliceridine) injection, a G protein biased mu-opioid receptor (MOR) ligand for the management of moderate-to-severe acute pain; TRV...

Get notified when there are updates to the investment portfolio of Awm Investment Company, Inc., based on Form 13F filings with the SEC.

Stay updated on Awm Investment Company, Inc. with notifications on news.